SCHEMBL35210425

SCHEMBL35210425

FC(F)(F)c1ccc(Oc2ccc(-c3noc(-c4ccncc4)n3)cc2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 11/20 0.66
S1PR3 Q99500 5/20 0.66
NPC1 O15118 6/20 0.63
RAB9A P51151 6/20 0.63
LMNA P02545 2/20 0.63
MAPT P10636 2/20 0.63
TP53 P04637 1/20 0.63
HPGD P15428 1/20 0.63
TSHR P16473 1/20 0.63
HTT P42858 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
THRB P10828 1/20 0.62
SMN1; SMN2 Q16637 2/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
CASP3 P42574 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13089335 0.89 LMNA (0.62) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL3070197 0.89 LMNA (0.62) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL3061859 0.89 LMNA (0.62) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL3053264 0.88 LMNA (0.60) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL3057686 0.88 LMNA (0.60) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL19968977 0.84 LMNA (0.56) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL20968200 0.84 RAB9A (0.74) S1PR1S1PR3NPC1RAB9ALMNA
Hydrochloric Acid SCHEMBL35210424 0.83 LMNA (0.55) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL20968198 0.83 S1PR1 (0.55) S1PR1S1PR3NPC1RAB9ALMNA
SCHEMBL26093703 0.83 NR1H4 (0.74) S1PR1NPC1RAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260125371-A1 METHOD FOR INHIBITING CLOSTRIDIOIDES DIFFICILE SPORE GERMINATION UNIVERSITY OF NOTRE DAME DU LAC (US) 2026-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125371-A1 METHOD FOR INHIBITING CLOSTRIDIOIDES DIFFICILE SPORE GERMINATION CYP8B1, SPOUT1, O60361 S1PR1 3111/4885S1PR3 2606/4885NPC1 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.